|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Salient Surgical Technologies Receives FDA Clearance for New AQUAMANTYS(R) Bipolar Sealer for Blunt Dissection
6/15/2011 6:44:56 AM
PORTSMOUTH, N.H.--(BUSINESS WIRE)-- Salient Surgical Technologies, Inc., a privately-held developer and innovator of advanced energy devices for use in surgical procedures, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the AQUAMANTYS bipolar sealer for use in blunt dissection. The company also recently received Japanese regulatory approval and European CE Mark clearance for commercial marketing of the device.
The new AQUAMANTYS device runs on Salient’s bipolar technology platform that uses proprietary TRANSCOLLATION® technology to enable surgeons to prevent and stop bleeding of soft tissue and bone during surgery. The new disposable sealer features cone-shaped electrodes that are designed to aid blunt dissection and provide hemostatic sealing across broad plains of tissue.
“We’ve incorporated Salient’s technology into our practice as of a result of its proven ability to help reduce blood loss and transfusion rates,” said T. Clark Gamblin, MD, MS, Chief of the Division of Surgical Oncology at the Medical College of Wisconsin. “In our experience, the new AQUAMANTYS bipolar electrode provides a safe and convenient means to achieve these clinical benefits during surgical oncology procedures, such as liver resections.”
About Salient Surgical Technologies
Salient Surgical Technologies, Inc. (www.salientsurgical.com) is a medical technology company that develops and markets advanced energy devices for use in surgical procedures. The company’s AQUAMANTYS® System uses patented TRANSCOLLATION® technology, which provides hemostatic sealing of soft tissue and bone tissue at the surgical site. This technology has been used to optimize care for more than 500,000 patients undergoing orthopaedic reconstruction, spine, orthopaedic trauma and surgical oncology procedures.
|
|
|
|
|
|
|
|
|
|
|